GlassScriptPhysician profile
Ankit Kansal
NPI 1467985044
$1,753.69
in general payments reported to CMS, 2019-2025
15 companies · $798 in 2025
The $798 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.38 · 2023: $445 · 2024: $457 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438 · Travel and Lodging: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.06 |
| Travel and Lodging | $262.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $431.97 | 2023-2025 | Nucala |
| Stryker Corporation | $397.40 | 2025 | Scopis Ent, Xpress Loprofile, Medline Industries, INC. |
| Genzyme Corporation | $231.31 | 2023-2025 | |
| Optinose US, INC. | $131.01 | 2022-2025 | |
| Amgen INC. | $130.83 | 2023-2025 | Tezspire |
| Kaleo, INC. | $93.36 | 2023 | Auvi-Q |
| Hikma Pharmaceuticals USA | $68.98 | 2023-2024 | Ryaltris |
| Pharming Healthcare, INC. | $62.17 | 2024-2025 | Ruconest |
| Integra Lifesciences Corporation | $47.24 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Takeda Pharmaceuticals U.S.A., INC. | $31.67 | 2024 | Eohilia |
| Novartis Pharmaceuticals Corporation | $31.67 | 2025 | |
| Boston Scientific Corporation | $28.68 | 2022 | |
| Phadia US INC. | $23.40 | 2023 | Immunocap |
| Paratek Pharmaceuticals, INC. | $22.58 | 2025 | Xhance |
| Alk-Abello, INC | $21.42 | 2025 | Grastek, Odactra, Ragwitek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Kansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.